Here are updates on two of our buys

Article Excerpt

Long-time readers know that we aim to keep you informed of important news about the stocks we cover. That means highlighting developments and plans that promise to bolster investor gains. Here are two buys that stand out this month: THERMO FISHER SCIENTIFIC INC., $504.89, is a buy. The company (New York symbol TMO; TSINetwork Rating: Average) (thermofisher.com; Shares o/s: 385.9 million; Market cap: $196.4 billion; Dividend yield: 0.3%) has been hired by Denmark-based Novo Nordisk A/S (New York symbol NVO) as its second contract manufacturer for the hugely popular weight-loss drug Wegovy. Thermo Fisher is doing the filling of the Wegovy injection pens at its factory in Greenville, North Carolina. That’s the process of filling vials with drugs and finishing the process of packaging the medicine for distribution. The Danish drugmaker is scrambling to boost output of the drug to meet soaring demand in the U.S. and after production problems at the factory in Brussels, Belgium, operated by its first contract manufacturer, Catalent. Wegovy launched in the…